Selection and management of hepatitis C virus-infected patients for the kidney transplant waiting list

Contributions to Nephrology

Volumn 176, Issue , 2012, Pages 66-76

  Roth, David ^a   Bloom, Roy ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; BIOPSY; CHRONIC KIDNEY FAILURE; HEALTH SURVEY; HEPATITIS C; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; PATHOLOGY; PATIENT SELECTION;

ANTIVIRAL AGENTS; BIOPSY; HEPATITIS C, CHRONIC; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; PATIENT SELECTION; POPULATION SURVEILLANCE; SEVERITY OF ILLNESS INDEX; WAITING LISTS;

EID: 84856834213     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000333774     Document Type: Article

References (37)

1. Pereira BJ, Natov SN, Bouthot BA, Murthy BVR, Ruthhazer R, Schmid CH, Levey AS: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998;53:1374-1381. (Pubitemid 28316901)
2. Bloom RD, Sayer G, Fa K, Constantinescu S, Abt P, Reddy R: Outcome of hepatitis C virus-infected kidney transplant candi-dates who remain on the waiting list. Am J Transplant 2005;5:139-144. (Pubitemid 40095138)
3. Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis JJ: The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients. Am J Kidney Dis 1997;29:608-614. (Pubitemid 27155284)
4. Roth D, Gaynor J, Reddy R, Ciancio G, Sageshima J, Kupin W, Guerra G, Chen L, Burke G: Outcomes in hepatitis C patients before and after kidney transplantation. J Am Soc Nephrol 2011;22:1152-1160.
5. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis. Aliment Pharmacol Ther 2004;20:1271-1277. (Pubitemid 40040073)
6. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G: Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005;5:1452-1461. (Pubitemid 40839438)
7. Vosnides GG: Hepatitis C in renal transplan-tation. Kidney Int 1997;52:834-861.
8. Hanafusa T, Ichikawa Y, Kishikawa H, et al: Retrospective study on the impact of hepa-titis C virus infection on kidney transplant patients over 20 years. Transplantation 1998;66:471-476. (Pubitemid 28415373)
9. Fissell RB, Bragg-Gresham JL, Woods JD, et al: Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004;65:2335-2342. (Pubitemid 38670020)
10. Martin P Carter D, Fabrizi F, Dixit V Conrad AJ, Artinian L, Peacock V, Han S, Wilkinson A, Lassman CR, Danovitch G: Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000;69:1479-1484. (Pubitemid 30238744)
11. Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contros MJ, Schiffman ML: Chronic hepatitis C infection in patients with end stage renal disease: char-acterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999;94:3576-3582.
12. Caramelo C, Ortiz A, Aguilera B, Porres JC, Navas S, Marriott E, Alberola MC, Alamo C, Galera A, Garron MP: Liver disease pat-terns in hemodialysis patients with antibod-ies to hepatitis C virus. Am J Kidney Dis 1993;22:822-828. (Pubitemid 23353614)
13. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF: Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipi-ents. Am J Gastroenterol 1999;94:159-163. (Pubitemid 29063461)
14. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Garnot F, Berthelot P, Brechot C: Hepatitis C virus RNA in anti-HCV positive hemodia-lyzed patients: significance and therapeutic implications. Kidney Int 1993;44:1097-2000.
15. Kidney Disease: Improving Global Outcomes. KDIGO Clinical Practice Guidelines for the Prevention, Diagnosis, Evaluation and Treatment of Hepatitis C in Chronic Kidney Disease. Kidney Int 2008;73(suppl 109):S1-S99.
16. Cotler SJ, Diaz G, Gundiapalli S, et al: Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 2002;35:191-195. (Pubitemid 34815860)
17. Brophy DF, Martin EJ, Carr SL, et al: The effect of uremia on platelet contractile force, clot elastin modulus and bleeding time in hemodialysis patients. Thromb Res 2007;119:723-729. (Pubitemid 46441415)
18. Pawa S, Ehrinpreis M, Mutchnick M, Janisse J, Dhar R, Siddiqui F: Percutaneous liver biopsy is safe in chronic hepatitis C patients with end stage renal disease. Clin Gastroenterol Hepatol 2007;5:1316-1320. (Pubitemid 350019056)
19. Furusyo N, Hayashi J, Kanamoto-Tanaka Y et al: Liver damage in hemodialysis patients with hepatitis C virus viremia: a prospective 10-year study. Dig Dis Sci 2000;45:2221-2228. (Pubitemid 32060396)
20. Schiavon L, Schiavon J, Filho RJ, Sampaio J, Lanzoni V, Silva A, Ferraz M: Simple blood tests as noninvasive markers of liver fibro-sis in hemodialysis patients with chronic hepatitis C virus infection. Hepatology 2007;46:307-314. (Pubitemid 47344764)
21. Munoz R, Ramirez E, Fernandez I, Martin A, Romero M, Romero E, Dominguez-Gil B, Hernandez A, Morales E, Andres A, Castellano G, Morales JM: Correlation between fibroscan, liver biopsy and clinical liver function in patients with hepatitis C virus infection after renal transplantation. Trans Proc 2009;41:2425-2426.
22. Bravo AA, Sheth SG, Chopra S: Liver biopsy. N Engl J Med 2001;344:495-500. (Pubitemid 32164902)
23. Regev A, Berho M, Jeffers LJ, et al: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infec-tion. Am J Gastroenterol 2002;97:2614-2618.
24. Sherlock S: The liver in Digestive Disease Week 1997. J Hepatol 1997;27:938-940. (Pubitemid 27454842)
25. Teh SH, Nagorney DM, Stevens SR, et al: Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 2007;132:1261-1269. (Pubitemid 46627576)
26. Eason JD, Gonwa TA, Davis CL, Sung RS, Gerber D, Bloom RD: Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK). Am J Transplant 2008;8:2243-2251.
27. Mathurin P Mouquet C, Poynard T, et al: Impact of hepatitis B and C virus on kid-ney transplantation outcome. Hepatology 1999;29:257-263. (Pubitemid 29024011)
28. Pereira BJ, Natov SN, Bouthot BA, et al: Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998;53:1374-1381. (Pubitemid 28316901)
29. Nakayama E, Akiba T, Marumo F, et al: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy J Am Soc Nephrol 2000;11:1896-1902.
30. Lecube A, Hernandez C, Genesca J, et al: High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury. Diabetes Care 2004;27:1171-1175. (Pubitemid 38579785)
31. Mehta SH, Brancati FL, Sulkowski MS, et al: Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infec-tion in the United States. Ann Intern Med 2000;133:592-599.
32. Gordon CE, Uhlig K, Lau J, Schmid CH, Levey AS, Wong JB: Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treat-ment efficacy and harms. Am J Kidney Dis 2008;51:263-277.
33. Gordon CE, Uhlig K, Schmid CH, Levey AS, Wong JB: Long-term viral negativity after interferon for chronic hepatitis C virus infec-tion in hemodialysis. Clin J Am Soc Nephrol 2011;6:2226-2234.
34. Delgado-Borrego A, Casson D, Schoenfeld D, et al: Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004;77:703-710. (Pubitemid 38366976)
35. Kamar N, Toupance O, Buchler M, et al: Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal trans-plantation. J Am Soc Nephrol 2003;14:2092-2098. (Pubitemid 36909917)
36. Cruzado JM, Casanovas-Taltavull T, Torras J, Baliellas C, Gil-Vernet S, Grinyo JM: Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance. Am J Transplant 2003;3:357-360. (Pubitemid 36407057)
37. Baid S, Tolkoff-Rubin N, Saidman S, et al: Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy Am J Transplant 2003;3:74-78. (Pubitemid 36306827)